Search research articles
Contact Us
Filters
Showing results (61-70 of 88) with videos related to
Page
of 9
Sort By:
Annals of the Rheumatic Diseases
|
August 12, 2006
Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis
C Turesson, L T H Jacobsson, G Sturfelt, et al.
Annals of the Rheumatic Diseases
|
November 21, 2008
Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials
T Bongartz, F C Warren, D Mines, et al.
Mayo Clinic Proceedings
|
June 8, 2001
Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept
M Baghai, D R Osmon, D M Wolk, et al.
Arthritis and Rheumatism
|
January 27, 1999
Induction therapy with an intravenous loading dose of azathioprine for treatment of refractory, active rheumatoid arthritis
E L Matteson, C H Orces, J Duffy, et al.
Radiology
|
March 1, 1992
Clinically occult avascular necrosis of the hip: prevalence in an asymptomatic population at risk
O Tervonen, D M Mueller, E L Matteson, et al.
Clinical and Experimental Rheumatology
|
May 29, 2015
Glucocorticoid usage in giant cell arteritis over six decades (1950 to 2009)
A Chandran, Pr D Udayakumar, T A Kermani, et al.
Seminars in Arthritis and Rheumatism
|
March 18, 2023
Survival of adults with rheumatoid arthritis associated interstitial lung disease - A systematic review and meta-analysis
H J Farquhar, N Beckert, L Beckert, et al.
Arthritis and Rheumatism
|
July 1, 1996
Pilot study of antithymocyte globulin in systemic sclerosis
E L Matteson, M I Shbeeb, T G McCarthy, et al.
Arthritis Care & Research
|
January 13, 2015
Cardiovascular risk profile at the onset of psoriatic arthritis: a population-based cohort study
F C Ernste, M Sánchez-Menéndez, K M Wilton, et al.
Rheumatology (Oxford, England)
|
February 26, 2004
How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial
E L Matteson, C M Weyand, J W Fulbright, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 88) with videos related to
Sort By:
Page
of 9
Annals of the Rheumatic Diseases
|
August 12, 2006
Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis
C Turesson, L T H Jacobsson, G Sturfelt, et al.
Annals of the Rheumatic Diseases
|
November 21, 2008
Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials
T Bongartz, F C Warren, D Mines, et al.
Mayo Clinic Proceedings
|
June 8, 2001
Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept
M Baghai, D R Osmon, D M Wolk, et al.
Arthritis and Rheumatism
|
January 27, 1999
Induction therapy with an intravenous loading dose of azathioprine for treatment of refractory, active rheumatoid arthritis
E L Matteson, C H Orces, J Duffy, et al.
Radiology
|
March 1, 1992
Clinically occult avascular necrosis of the hip: prevalence in an asymptomatic population at risk
O Tervonen, D M Mueller, E L Matteson, et al.
Clinical and Experimental Rheumatology
|
May 29, 2015
Glucocorticoid usage in giant cell arteritis over six decades (1950 to 2009)
A Chandran, Pr D Udayakumar, T A Kermani, et al.
Seminars in Arthritis and Rheumatism
|
March 18, 2023
Survival of adults with rheumatoid arthritis associated interstitial lung disease - A systematic review and meta-analysis
H J Farquhar, N Beckert, L Beckert, et al.
Arthritis and Rheumatism
|
July 1, 1996
Pilot study of antithymocyte globulin in systemic sclerosis
E L Matteson, M I Shbeeb, T G McCarthy, et al.
Arthritis Care & Research
|
January 13, 2015
Cardiovascular risk profile at the onset of psoriatic arthritis: a population-based cohort study
F C Ernste, M Sánchez-Menéndez, K M Wilton, et al.
Rheumatology (Oxford, England)
|
February 26, 2004
How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial
E L Matteson, C M Weyand, J W Fulbright, et al.
Page
of 9